Finance

Lists
ALIVUS:NSE
Alivus Life Sciences Ltd
1 323,40 INR
-1,03%
(-13,80) 1D
9-окт., 15:30:00 GMT+5:30  ·   INR
All symbols
SymbolPriceChange% Change
Generating top insights for ALIVUS...
Open
1 332,00 INR
High
1 350,50 INR
Low
1 298,00 INR
Mkt. cap
162,48 млд
Avg. vol.
177,16 миң
Volume
131,73 миң
Dividend
0,38%
Quarterly dividend
1,25 INR
Ex-dividend date
2026-ж., 1-сен.
P/E ratio
26,99
52-wk high
1 493,80 INR
52-wk low
819,00 INR
EPS
49,03 INR
No. of employees
2 миң
Open
1 332,00 INR
High
1 350,50 INR
Low
1 298,00 INR
Mkt. cap
162,48 млд
Avg. vol.
177,16 миң
Volume
131,73 миң
Dividend
0,38%
Quarterly dividend
1,25 INR
Ex-dividend date
2026-ж., 1-сен.
P/E ratio
26,99
52-wk high
1 493,80 INR
52-wk low
819,00 INR
EPS
49,03 INR
No. of employees
2 миң
News stories
From web sources and news partners
About Alivus Life Sciences Ltd
CEOYasir Rawjee
Employees2,27 миң
Founded2001
Headquarters-
SectorPharmaceutical industry
Websitealivus.com
Last report
2026-ж., 31-июл.
Fiscal period
Q1 2027
13,01 INR / 12,10 INR
+7,52%beat
Revenue / Est. (INR)
6,40 млд / 6,68 млд
-4,06%miss
Fiscal Q1 2027 earnings call
Waiting for the earnings call
At a glance
Insights from the latest news and reports
Previous reportsAll values in INR
Loading Previous Earnings...
Revenue
Net income
All values in INR
2025-ж. сен.
2025-ж. дек.
2026-ж. мар.
2026-ж. июн.
Revenue
5,88 млд
6,73 млд
6,89 млд
6,40 млд
Cost of goods sold
2,49 млд
2,76 млд
3,45 млд
2,55 млд
Cost of revenue
2,49 млд
2,76 млд
3,45 млд
2,55 млд
Research and development expenses
-
-
-
-
Total research and development expenses
-
-
-
-
Selling, general, and admin expenses
664,00 млн
663,70 млн
965,39 млн
682,45 млн
Operating expense
1,78 млд
1,85 млд
1,49 млд
1,94 млд
Total operating expenses
4,27 млд
4,61 млд
4,94 млд
4,49 млд
Operating income
1,61 млд
2,12 млд
1,95 млд
1,91 млд
Other non operating income
147,20 млн
139,28 млн
-368,69 млн
224,01 млн
EBT including unusual items
1,74 млд
1,98 млд
2,16 млд
2,12 млд
EBT excluding unusual items
1,74 млд
2,24 млд
1,78 млд
2,12 млд
Income tax expense
441,11 млн
481,31 млн
531,38 млн
521,47 млн
Effective tax rate
25,33%
24,26%
24,62%
24,57%
Other operating expenses
934,91 млн
988,28 млн
325,80 млн
1,05 млд
Net income
1,30 млд
1,50 млд
1,63 млд
1,60 млд
Net profit margin
22,11%
22,33%
23,60%
25,00%
Earnings per share
10,58
13,80
13,22
13,01
Interest and investment income
-
-
9,66 млн
-
Interest expense
-13,18 млн
-14,94 млн
-13,09 млн
-13,07 млн
Net interest expenses
-13,18 млн
-14,94 млн
-3,43 млн
-13,07 млн
Depreciation and amortization charges
184,35 млн
196,58 млн
202,00 млн
205,85 млн
EBITDA
1,78 млд
2,25 млд
2,11 млд
2,10 млд
Gain or loss from assets sale
-
-
-
-
AI content may include mistakes. Learn more
Google колдонмолору